NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Array Biopharma (ARRY)

Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 06 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma

Array Biopharma Opened at 7.13 and Closed at: 6.81, which is -4.85% of previous session's close. It moved within a range of 6.63 and 7.20
The session was a Bearish session with an average volume of 8048281, which is -8.28% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.

A Dead cross was found 5 days back on mid term averages

Support for tomorrow is 6.44 and resistance for tomorrow is 7.01
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 6.56, 6.31 resistance for tomorrow's hourly charts is 7.13, 7.45

10 Day SMA for Array Biopharma (ARRY) is 8.36 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Array Biopharma (ARRY) is 9.82 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Array Biopharma (ARRY) is 10.11 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 9.26 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Array Biopharma is 8.42 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Array Biopharma is at 9.82 and 200 DMA is at 8.42, while 50 DMA and 100 DMA are at 10.11 and 9.26 respectively

Array Biopharma (ARRY) moving average of 20 SMA is at 9.82 and 20 EMA is at 9.14

Array Biopharma (ARRY) moving average of 50 SMA is at 10.11 and 50 EMA is at 9.64

Array Biopharma (ARRY) moving average of 100 SMA is at 9.26 and 100 EMA is at 9.31

Array Biopharma (ARRY) moving average of 200 SMA is at 8.42 and 200 EMA is at 8.66

Unitedhealth Group has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Unitedhealth Group, about 46.78% more returns!

Pfizer Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Pfizer Inc, about 42.87% more returns!

Molina Healthcare has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Molina Healthcare, about 56.15% more returns!

Inspire Medical has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Inspire Medical, about 37.83% more returns!

Charles River has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Charles River, about 36.82% more returns!

Sangamo Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Sangamo Therapeutics, about 37.87% more returns!

Riot Blockchain has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Riot Blockchain, about 37.53% more returns!

Quidel Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Quidel Corporation, about 14.06% more returns!

Ovid Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 64.39% more returns!

Array Biopharma has performed better than Iterum Therapeutics in short term. Holding Array Biopharma could be a better choice for now!

Inogen Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Inogen Inc, about 58.61% more returns!

Galmed Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Galmed Pharmaceuticals, about 39.93% more returns!

Eyegate Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 42.34% more returns!

Exelixis Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Exelixis Inc, about 37.39% more returns!

Axsome Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 31.47% more returns!

Argenx Se has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Argenx Se, about 29.54% more returns!

Amgen Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Amgen Inc, about 41.2% more returns!

Array Biopharma Technical analysis of indicators

Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.

Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Array Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 7.91 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.

Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ARRY Experts View which covers a lot of information including buying and selling signals

ARRY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet